Tonix Pharma (TNXP) Tops Q1 EPS by 284c
Tonix Pharma (NASDAQ: TNXP) reported Q1 EPS of $2.84. Revenue for the quarter came in at $2.43 million versus the consensus estimate of $4.2 million.
For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.
